Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherBrowse by ChannelAbout the NetworkJoin the NetworkProductsSub-MenuProducts OverviewBlog ProBlog PlusBlog PremierMicrositeSyndication PortalsAbout UsContactSubscribeSupport
Book a Demo
Search
Close

SCOTUS May Resolve Circuit Split on the Specificity Required of False Claims Act Claims: Relief or More FCA Grief for Providers?

By William J. Spratt, Jr., Jeremy Burnette & Lauren Gandle on June 17, 2022
Email this postTweet this postLike this postShare this post on LinkedIn

Currently, providers have different risks of potential False Claims Act (“FCA”) liability depending on where they are geographically located due to the difference in the standards required by the U.S. Courts of Appeals regarding the level of specificity when relators (whistleblowers) plead FCA violations.  The FCA imposes civil liability on any person requesting government funds or property who “knowingly presents . . . a false or fraudulent claim for payment or approval.” 31 U.S.C. § 3729(a)(1)(A).  A pleading, “alleging fraud or mistake . . . must state with particularity the circumstances constituting fraud or mistake.” Fed. R. Civ. P. 9(b) (emphasis added).  And the Circuits of the U.S. Courts of Appeals are split on what information is required in a relator’s FCA complaint under Rule 9(b) to avoid a dismissal of the complaint. The U.S. Supreme Court may resolve the difference in the standards if it grants certiorari in Johnson, et al. v. Bethany Hospice & Palliative Care of Ga., LLC.

The Circuit Split

Two circuit courts have concluded there should be a high threshold of “particularity” for FCA pleadings under Rule 9(b) because of the potential criminal consequences and treble damages for an FCA violation. The Eleventh and Sixth Circuit Courts of Appeals agree that an FCA complaint should include an example of a specific fraudulent claim made to the U.S. government. Johnson, et al. v. Bethany Hospice & Palliative Care of Ga., LLC, 853 F. App’x 496, 501 (11th Cir. 2021) (finding a relator must allege an actual submission of a false claim with “some indicia of reliability”); U.S. ex rel. Owsley v. Fazzi Assocs., Inc., 16 F.4th 192, 197 (6th Cir. 2021) (finding an FCA complaint should include a “specific representative claim”).

The Seventh Circuit Court of Appeals, however, has ruled that while FCA claims should be precise and substantiated, specific details about a submitted false claim are not necessarily needed at the pleadings stage, and more specific information can be required as the litigation proceeds. U.S. v. Molina Healthcare of Ill., Inc., 17 F.4th 732, 739, 741 (7th Cir. 2021) (noting a case does not have to be proven in the complaint).

Consequently, there is disagreement among the Circuit Courts of Appeals regarding whether an FCA allegation must include specific examples of false claims submitted to the U.S. government.  As a result, a relator in two circuits would be required to have and plead more specific information, while a relator in the Seventh Circuit would have a much lower burden and could use the discovery process to determine if there is actually an FCA violation.

Response to the Circuit Split

The U.S. Supreme Court requested the U.S. Solicitor General’s feedback on the level of specificity required in FCA allegations to address the above circuit split. Recently, the U.S. Solicitor General Elizabeth B. Prelogar responded to this request saying that the courts have “largely converged on a more flexible standard.” Brief for U.S. as Amicus Curiae at 15, Johnson, et al., v. Bethany Hospice and Palliative Care, LLC (No. 21-462). This more flexible standard, the Solicitor General argued, requests either a showing of specific false claims or allegations of fraud containing some “indicia of reliability” to support an inference that a false claim was submitted.  Id. The Solicitor General stated the Circuit Courts of Appeals are generally using similar standards, with some different caveats. Id. at 16. The circuits, she asserted, are just coming to different decisions as they make individualized assessments of various allegations. Id. at 17-18. The Solicitor General stated that this pleading standard does not warrant the Supreme Court’s review. Id. at 18.

However, in responding to the Solicitor General’s brief, Petitioners challenged the notion that circuit courts have converged on a similar standard. Supplemental Brief for Petitioners at 3, Jolie Johnson, et al., v. Bethany Hospice and Palliative Care of Ga., LLC (No. 21-462). Rather, Petitioners asserted that the circuits are indeed split and relators and providers are subject to very different standards in understanding what must be stated with particularity. Id. at 4. One side of the circuit split interprets Rule 9(b)’s particularity requirement as needing particularity in alleging the specific nature of the false claims themselves, while other circuits require particularity in describing the circumstances surrounding a fraudulent scheme, leaving the specific nature of the false claims to be determined in discovery. Id. The latter approach may not require any specific information about claims for payment. Id. at 5. Petitioners describe these varying approaches as an “undeniable circuit conflict.” Id. at 6.

Despite the U.S. Solicitor General’s feedback, providers still need clarity regarding the FCA pleading standards and what level of particularity is required under Rule 9(b) for an FCA complaint to survive dismissal. Providers under a lax standard could be required to defend themselves against protracted FCA litigation akin to a “fishing expedition.”  Providers under a more stringent standard would have a better opportunity to have a case dismissed at the earliest stage.  Similarly, relators and the government would benefit from a more uniform standard. If the U.S. Supreme Court grants the certiorari petition, its decision will have a huge impact on the future of FCA litigation.

Photo of William J. Spratt, Jr. William J. Spratt, Jr.

A former healthcare administrator, Bill Spratt represents large healthcare companies and private equity sponsors in multi-jurisdictional transactions, traversing complex state and federal laws and regulations. He counsels institutional and non-institutional healthcare providers including hospitals, ambulatory surgery centers, outpatient and urgent care centers, skilled…

A former healthcare administrator, Bill Spratt represents large healthcare companies and private equity sponsors in multi-jurisdictional transactions, traversing complex state and federal laws and regulations. He counsels institutional and non-institutional healthcare providers including hospitals, ambulatory surgery centers, outpatient and urgent care centers, skilled nursing facilities, hospices, home health agencies, health maintenance organizations, clinical laboratories, radiation therapy centers, durable medical equipment companies, physician networks, and specialty physician groups.

Read more about William J. Spratt, Jr.Email
Show more Show less
Photo of Jeremy Burnette Jeremy Burnette

Jeremy Burnette is a seasoned healthcare litigator with substantial experience working within the complex regulatory framework in which providers operate. Jeremy’s practice focuses on representing healthcare providers in a variety of complex litigation matters and disputes, including whistleblower or government investigations or claims…

Jeremy Burnette is a seasoned healthcare litigator with substantial experience working within the complex regulatory framework in which providers operate. Jeremy’s practice focuses on representing healthcare providers in a variety of complex litigation matters and disputes, including whistleblower or government investigations or claims, state licensure board investigations or enforcement actions, government or private payor audit and recoupment actions, medical staff matters, practice dissolutions, and commercial disputes.  Jeremy also advises healthcare providers in regulatory compliance matters and serves as counsel to providers’ internal compliance committees.

Read more about Jeremy BurnetteEmail
Show more Show less
Photo of Lauren Gandle Lauren Gandle

Lauren Gandle focuses her practice on healthcare law, including representing insurance companies in litigation and general liability matters. Her experience includes researching legal issues, drafting memoranda on healthcare topics including HIPAA, healthcare research misconduct, and drafting license agreements with hospital systems.

Email
  • Posted in:
    Health Care
  • Blog:
    Health Law Rx
  • Organization:
    Akerman LLP
  • Article: View Original Source

LexBlog, Inc. logo
Facebook LinkedIn Twitter RSS
Real Lawyers
99 Park Row
  • About LexBlog
  • Careers
  • Press
  • Contact LexBlog
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Terms of Service
  • RSS Terms of Service
  • Products
  • Blog Pro
  • Blog Plus
  • Blog Premier
  • Microsite
  • Syndication Portals
  • LexBlog Community
  • Resource Center
  • 1-800-913-0988
  • Submit a Request
  • Support Center
  • System Status
  • Resource Center
  • Blogging 101

New to the Network

  • Tennessee Insurance Litigation Blog
  • Claims & Sustains
  • New Jersey Restraining Order Lawyers
  • New Jersey Gun Lawyers
  • Blog of Reason
Copyright © 2025, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo